Antimicrobials: New and Old Molecules in the Fight Against Multi-resistant Bacteria
Editat de Flavia Marinelli, Olga Genillouden Limba Engleză Hardback – 15 oct 2013
This book closely examines the latest developments in the field of antibacterial research and development. It starts with an overview of the growing prevalence of resistant Gram-positive and Gram-negative pathogens, including their various resistance mechanisms, prevalence, risk factors and therapeutic options. The focus then shifts to a comprehensive description of all major chemical classes with antibacterial properties, their chemistry, mode of action, and the generation of analogs; information that provides the basis for the design of improved molecules to defeat microbial infections and combat the emerging resistances. In closing, recently developed compounds already in clinical use, those in preclinical or first clinical studies, and a number of promising targets to be exploited in the discovery stage are discussed.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1040.38 lei 6-8 săpt. | |
Springer Berlin, Heidelberg – 23 aug 2016 | 1040.38 lei 6-8 săpt. | |
Hardback (1) | 1045.23 lei 6-8 săpt. | |
Springer Berlin, Heidelberg – 15 oct 2013 | 1045.23 lei 6-8 săpt. |
Preț: 1045.23 lei
Preț vechi: 1100.24 lei
-5% Nou
Puncte Express: 1568
Preț estimativ în valută:
200.07€ • 215.12$ • 166.79£
200.07€ • 215.12$ • 166.79£
Carte tipărită la comandă
Livrare economică 19 decembrie 24 - 02 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783642399671
ISBN-10: 3642399673
Pagini: 300
Ilustrații: VIII, 364 p. 71 illus., 10 illus. in color.
Dimensiuni: 155 x 235 x 30 mm
Greutate: 0.65 kg
Ediția:2014
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
ISBN-10: 3642399673
Pagini: 300
Ilustrații: VIII, 364 p. 71 illus., 10 illus. in color.
Dimensiuni: 155 x 235 x 30 mm
Greutate: 0.65 kg
Ediția:2014
Editura: Springer Berlin, Heidelberg
Colecția Springer
Locul publicării:Berlin, Heidelberg, Germany
Public țintă
ResearchCuprins
Part I Current trends in antibiotics, pathogens and medical needs.- Part II Families of novel candidates and conventional antibiotics.
Textul de pe ultima copertă
Reports on the emergence and prevalence of resistant bacterial infections in hospitals and communities raise concerns that we may soon no longer be able to rely on antibiotics as a way to control infectious diseases. Effective medical care would require the constant introduction of novel antibiotics to keep up in the “arms race” with resistant pathogens.
This book closely examines the latest developments in the field of antibacterial research and development. It starts with an overview of the growing prevalence of resistant Gram-positive and Gram-negative pathogens, including their various resistance mechanisms, prevalence, risk factors and therapeutic options. The focus then shifts to a comprehensive description of all major chemical classes with antibacterial properties, their chemistry, mode of action, and the generation of analogs; information that provides the basis for the design of improved molecules to defeat microbial infections and combat the emerging resistances. In closing, recently developed compounds already in clinical use, those in preclinical or first clinical studies, and a number of promising targets to be exploited in the discovery stage are discussed.
This book closely examines the latest developments in the field of antibacterial research and development. It starts with an overview of the growing prevalence of resistant Gram-positive and Gram-negative pathogens, including their various resistance mechanisms, prevalence, risk factors and therapeutic options. The focus then shifts to a comprehensive description of all major chemical classes with antibacterial properties, their chemistry, mode of action, and the generation of analogs; information that provides the basis for the design of improved molecules to defeat microbial infections and combat the emerging resistances. In closing, recently developed compounds already in clinical use, those in preclinical or first clinical studies, and a number of promising targets to be exploited in the discovery stage are discussed.
Caracteristici
Examines the latest developments in antibacterial research and drug design Integrates basic and clinical aspects Written by international experts Includes supplementary material: sn.pub/extras